The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...

Clearside Biomedical, Inc. has announced the presentation of two subgroup analyses from its ODYSSEY Phase 2b clinical trial ... advancement in the company's research portfolio.

Universities are scrambling after the National Institutes of Health announced a plan to cut millions of dollars in research ...

Blue Cross and Blue Shield of Kansas announced a $2.5 million donation at a Monday ceremony at WSU’s Marcus Welcome Center.

Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing in the development of oral recombinant vaccines with a market capitalization of approximately $159 million, announced on Monday an ...

Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has received an average recommendation of “Buy” from the six research firms that are currently covering the company, Ratings reports. Six ...

UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received ...

Union Minister Dr. Jitendra Singh today launched Automated Bio Medical Waste Treatment Plant at AIIMS New Delhi. The ...

Share on Facebook Share on Twitter Blue Cross and Blue Shield of Kansas has announced a $2.5 million donation to Wichita ...

Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.